It has been reported that the incidence of FLT3/ITD in adult AML is about 20–35%, whereas pediatric AML has a reported prevalence of 15% for FLT3/ITD, which was lower than in adults2–12. This evidence concerns the gene FLT3 and acute myeloid leukemia.